Some studies in ovarian cancer showed similar results that increased expression of ATP7A mediated resistance to platinum derivatives in cancer cells and was associated with poor survival in ovarian cancer patients during platinum drug-based treatments [10,11]. The gene discussed is ATP7A; the disease is cancer.